Clinical Trial: Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653009) titled 'Transcutaneous Auricular Vagus Nerve Stimulation in Psoriatic Arthritis' on June 02.

Brief Summary: This prospective single-center interventional study aims to investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on disease activity, pain, quality of life, autonomic dysfunction symptoms, and inflammatory biomarkers in patients with psoriatic arthritis (PsA). Participants diagnosed with PsA according to the Classification Criteria for Psoriatic Arthritis (CASPAR) will undergo non-invasive auricular vagus nerve stimulation using the Vagustim device. Clinical outcomes including the Disease Activity Index ...